Stemtech (STEK) Equity Ratio (2012 - 2025)

Stemtech has disclosed Equity Ratio across 14 years of filings, most recently posting 2.45 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 2.45, down 77.01% year-over-year; the trailing twelve-month figure through Dec 2025 was 2.45 (down 77.01% YoY), and the FY2025 annual result was 2.45, down 77.01% from the prior year.
• Equity Ratio came in at 2.45 for Q4 2025 at Stemtech, down from 1.54 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.23 in Q3 2023 to a low of 6.1 in Q2 2022.
• The 5-year median for Equity Ratio is 1.08 (2022), against an average of 1.4.
• Across the five-year window, Equity Ratio surged 86.25% in 2023 and sank 83.18% in 2024, its largest moves.
• Stemtech's Equity Ratio stood at 0.7 in 2021, then retreated by 6.16% to 0.74 in 2022, then retreated by 1.49% to 0.75 in 2023, then tumbled by 83.18% to 1.38 in 2024, then tumbled by 77.01% to 2.45 in 2025.
• The last three Equity Ratio figures came in at 2.45 (Q4 2025), 1.54 (Q3 2025), and 1.47 (Q2 2025), per Business Quant data.